Loading stock data…
$55.59-0.60 (-1.08%)
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions.
Bruker Corporation in the Healthcare sector is trading at $55.59 with a market capitalization of $8.5B. Wall Street consensus targets $63.83 (12 analysts), implying a +14.8% move over the next 12 months. The stock is currently 17% below its 52-week high of $66.98, remaining 11.8% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality. Risk note: RSI 26 is oversold, raising the odds of a near-term bounce. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $838.50M↑ | $823.40M↓ | $977.20M↑ | $860.50M↑ | $797.40M |
| Gross Profit | $416.00M↑ | $379.80M↓ | $449.20M↑ | $379.40M↑ | $357.90M |
| Operating Income | $82.80M↑ | $36.40M↓ | $111.80M↑ | $35.00M↑ | $26.30M |
| Net Income | -$52.00M↓ | $14.40M↓ | $26.00M↑ | -$59.60M↓ | $7.60M |
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BS...